BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12716500)

  • 21. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.
    Maggiolo F; Ravasio L; Ripamonti D; Gregis G; Quinzan G; Arici C; Airoldi M; Suter F
    Clin Infect Dis; 2005 Jan; 40(1):158-63. PubMed ID: 15614706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring HIV treatment adherence in clinical practice.
    Hecht FM
    AIDS Clin Care; 1998 Aug; 10(8):57-9. PubMed ID: 11365682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients.
    Park WB; Choe PG; Kim SH; Jo JH; Bang JH; Kim HB; Kim NJ; Oh M; Choe KW
    J Intern Med; 2007 Mar; 261(3):268-75. PubMed ID: 17305649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to generic reverse transcriptase inhibitor-based antiretroviral medication at a Tertiary Center in North India.
    Wanchu A; Kaur R; Bambery P; Singh S
    AIDS Behav; 2007 Jan; 11(1):99-102. PubMed ID: 16607479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
    Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
    Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient self-report as a marker of adherence to antiretroviral therapy.
    Ho CF; Fong OW; Wong KH
    Clin Infect Dis; 2002 Jun; 34(11):1534-5. PubMed ID: 12015702
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depression and patterns of self-reported adherence to antiretroviral therapy in Rwanda.
    Wroe EB; Hedt-Gauthier BL; Franke MF; Nsanzimana S; Turinimana JB; Drobac P
    Int J STD AIDS; 2015 Mar; 26(4):257-61. PubMed ID: 24828554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-adherence to HIV antiretroviral medications: 'The drugs are working and I'm a continuing success story'.
    Cummins D; Trotter G; Millar KH
    Aust J Adv Nurs; 2002 Dec-2003 Feb; 20(2):15-8. PubMed ID: 12537147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pill taking 'routinization': a critical factor to understanding episodic medication adherence.
    Ryan GW; Wagner GJ
    AIDS Care; 2003 Dec; 15(6):795-806. PubMed ID: 14617501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.
    Bruce JM; Hancock LM; Lynch SG
    Mult Scler; 2010 Jan; 16(1):112-20. PubMed ID: 19995835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to use of electronic adherence monitoring in an HIV clinic.
    Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
    Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to HIV antiretrovirals among persons with serious mental illness.
    Wagner GJ; Kanouse DE; Koegel P; Sullivan G
    AIDS Patient Care STDS; 2003 Apr; 17(4):179-86. PubMed ID: 12737641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electronic monitoring gains more acceptance.
    AIDS Alert; 1998 Feb; 13(2):21-2. PubMed ID: 11365038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing adherence to antiretrovirals: strategies and regimens.
    Stone VE
    MedGenMed; 2002 Jul; 4(3):22. PubMed ID: 12466765
    [No Abstract]   [Full Text] [Related]  

  • 37. Adherence--sticking to the evidence.
    Sherr L
    AIDS Care; 2000 Aug; 12(4):373-5. PubMed ID: 11091769
    [No Abstract]   [Full Text] [Related]  

  • 38. Electronic monitoring: adherence assessment or intervention?
    Wagner GJ; Ghosh-Dastidar B
    HIV Clin Trials; 2002; 3(1):45-51. PubMed ID: 11819185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to antiretroviral therapy: are we doing enough?
    Read T; Mijch A; Fairley CK
    Intern Med J; 2003; 33(5-6):254-6. PubMed ID: 12752896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal recall period and response task for self-reported HIV medication adherence.
    Lu M; Safren SA; Skolnik PR; Rogers WH; Coady W; Hardy H; Wilson IB
    AIDS Behav; 2008 Jan; 12(1):86-94. PubMed ID: 17577653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.